Hiramoto R N, Cox P J, Hiramoto N S, Ghanta V K
J Immunol. 1984 Dec;133(6):3424-8.
In this report we provide evidence that suggests that MOPC 104E may come under regulation in highly immunosuppressed hosts depleted of T cells. Mice that are adult thymectomized, total body irradiated, and transplanted with bone marrow cells were able to resist the growth of MOPC 104E cells. Spleen cells from such animals had low NK activity and no cytotoxicity against MOPC 104E, and poor response to Con A, PHA, and LPS. The animals were deficient in Lyt-1+ and Lyt-2+ cells. The growth of MOPC 104E cells was measured by using the circulating level of MOPC 104E IgM in vivo in mice treated by different modalities. We observed that inhibition of tumor growth in vivo varied with the treatment of the host. Growth was inhibited in the host in the following order: ATXBM greater than XBM greater than NORMAL greater than ATx mice.
在本报告中,我们提供的证据表明,MOPC 104E在T细胞耗竭的高度免疫抑制宿主中可能受到调控。成年胸腺切除、全身照射并移植骨髓细胞的小鼠能够抵抗MOPC 104E细胞的生长。此类动物的脾细胞自然杀伤活性低,对MOPC 104E无细胞毒性,对刀豆蛋白A、植物血凝素和脂多糖反应不佳。这些动物缺乏Lyt-1+和Lyt-2+细胞。通过测量不同处理方式的小鼠体内MOPC 104E IgM的循环水平来检测MOPC 104E细胞的生长。我们观察到,体内肿瘤生长的抑制因宿主处理方式而异。宿主中肿瘤生长的抑制顺序如下:成年胸腺切除并移植骨髓细胞组大于移植骨髓细胞组大于正常组大于胸腺切除小鼠组。